Skip to main navigation
HCW Biologics, Inc. Logo
  • Home
  • Overview
  • News & Publications
    News Releases Publications
  • Events & Presentations
  • Governance
    Documents & Charters Leadership and Board Committee Composition
  • Stock
    Stock Quote & Chart Analyst Coverage
  • Financials
    SEC Filings
  • IR Resources
    Email Alerts Contact Us

Event Details

A “kick and expand” strategy to generate large numbers of CIML NK cells for adoptive cell therapy for the treatment of cancer using novel fusion proteins HCW9201 and HCW9206 – Immunology 2022

May 9, 2022

Supporting Materials

A “kick and expand” strategy to generate large numbers of CIML NK cells for adoptive cell therapy for the treatment of cancer using novel fusion proteins HCW9201 and HCW9206 – Immunology 2022 1.1 MB
  • © HCW Biologics, Inc. 2021 - 2023